Niemann-Pick Disease Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
Orphazyme Reports Encouraging Arimoclomol Clinical Trial Top-Line Data in Niemann-Pick Disease Type C (NPC)
Copenhagen, September 28, 2018 – Orphazyme A/S, a biopharmaceutical company dedicated to developing treatments for patients living with rare diseases, today announced encouraging top-line results for its clinical Phase II/III trial with orally... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - September 28, 2018 Category: Pharmaceuticals Source Type: clinical trials
Safety and Tolerability Study of VTS-270 in Pediatric Participants With Niemann-Pick Type C (NPC) Disease
Condition: Niemann-Pick Disease, Type C Intervention: Drug: VTS-270 Sponsor: Vtesse, Inc., a Mallinckrodt Pharmaceuticals Company Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 27, 2018 Category: Research Source Type: clinical trials
CTD Holdings Discusses its Phase I Clinical Trial for Intravenous Use of Trappsol ® Cyclo™ in Niemann-Pick Disease Type C
ALACHUA, Fla., Aug. 30, 2018 (GLOBE NEWSWIRE) -- CTD Holdings, Inc. (OTCQB: CTDH), a clinical stage biotechnology company that develops cyclodextrin-based products for the treatment of disease with unmet medical need, responds today to community... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - August 30, 2018 Category: Pharmaceuticals Source Type: clinical trials
Study of IV VTS-270 for Infantile Liver Disease Associated With Niemann-Pick Disease, Type C
Condition: Niemann-Pick Disease, Type C Intervention: Drug: 2-Hydroxypropyl-Beta-Cyclodextrin Sponsors: Washington University School of Medicine; Johns Hopkins University; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 20, 2018 Category: Research Source Type: clinical trials